Cosciens Biopharma Inc
(CSCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-1993 | 08-1993 | 05-1993 | 02-1993 | 11-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,304 | N/A | N/A | N/A |
| Depreciation Amortization | N/A | 545 | N/A | N/A | N/A |
| Other Working Capital | N/A | 684 | N/A | N/A | N/A |
| Other Operating Activity | 0 | 899 | 0 | 0 | 0 |
| Operating Cash Flow | $N/A | $-1,176 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -511 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-511 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 1,840 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $1,840 | $N/A | $N/A | $N/A |
| Beginning Cash Position | N/A | 1,154 | N/A | N/A | N/A |
| End Cash Position | N/A | 1,307 | N/A | N/A | N/A |
| Net Cash Flow | $N/A | $153 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -1,176 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -1,176 | 0 | 0 | 0 |